procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
Published 2 years ago • 93 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
8:10
mindact: adjuvant chemotherapy in breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
2:46
adjuvant chemotherapy for breast cancer: who needs it?
-
4:13
genomic predictors for treatment selection in er breast cancer: tailorx, mindact, and rxponder
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
1:15
remaining questions regarding the use of adjuvant chemotherapy in breast cancer
-
3:11
time for change: introducing genomic predictors in er breast cancer
-
3:56
using mammaprint to select patients who may not need adjuvant chemotherapy – the results of mindact
-
3:55
evolution of genomic tools shaping treatment decision making in breast cancer
-
2:00
genomic testing in early breast cancer: mammaprint & blueprint
-
1:01
exploring extended adjuvant chemotherapy for luminal cancers
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
2:31
adjuvant/neoadjuvant therapy trials for breast cancer at sabcs 2021
-
7:42
breast cancer: genomic testing for adjuvant therapy
-
28:06
the role of genomics in breast cancer management by fatima cardoso, md
-
9:35
mindact long-term results: 70-gene signature mammaprint to guide adjuvant chemotherapy use in br...
-
1:30
utilizing genomic assays for decision making in early stage breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer